(Health Korea News / Lee Si-woo) The dispute over management rights between Hanmi Science’s families appears to be turning into a muddy fight. Hanmi Science (CEO Lim Jong-hoon), which is scheduled to hold an extraordinary shareholders’ meeting on the 28th, filed a criminal complaint against the three-party alliance (Shin Dong-guk, Song Young-sook, and Lim Joo-hyun) and the representative of the proxy voting company for them.
On the 15th, Hanmi Science filed a complaint with Gangnam Police Station in Seoul against the three-party alliance, including Hanyang Precision Chairman Shin Dong-guk, Hanmi Pharmaceutical Group Chairman Song Young-sook and Vice Chairman Lim Joo-hyun, and representatives of companies entrusted with voting rights solicitation work by them, on charges of hierarchy and obstruction of business. He said he did.
Chairman Song Young-sook (born in 1948), a member of the tripartite alliance, is the mother of CEO Lim Jong-hoon (born in 1977), and Vice Chairman Lim Joo-hyun (born in 1974) is CEO Lim’s older sister. In the end, a laughable skit unfolds in which the son accuses his mother and sister. (See related article below)
An official from Hanmi Science said, “We have confirmed a series of cases where the three-party alliance conspired with proxy voting solicitors to steal the company logo and encourage shareholders to make wrong decisions with false information, so we inevitably decided to file a criminal complaint.” “In the report, it was confirmed that false information, such as ‘The National Pension Service has also turned into a three-party alliance’ and ‘We are increasing paid-in capital,’ and that information that has not been decided or confirmed is being passed on to shareholders as if it were true,” explained the background of filing the complaint. did it
“Spreading false information, even mentioning government agencies such as the National Pension Service… It is a crime of obstruction of business under the Criminal Act.”
It has been reported that Hanmi Science recently determined that a variety of illegal activities were taking place in the process of recommending proxy voting by the three-party alliance and began a legal review. The explanation is that it was confirmed that a number of agents for the three-party alliance that were competing for votes began using the Hanmi Science company logo, etc. on business cards without permission at the same time they began their activities.
An official from Hanmi Science said, “Recently, our company logo was printed on printed materials and business cards (photos) provided by the voting rights agent of the three-party alliance when visiting shareholders.” He added, “In particular, according to confirmed face-to-face and phone calls, there was no information about Hanmi Science executives. “Not only are they using defamatory slander, but they are even citing government agencies such as the National Pension Service to make shareholders believe false information,” he criticized.
An official in the legal community said, “Using the company logo without permission to deliver false information to shareholders has a very high risk of distorting the results of the extraordinary shareholders’ meeting.” He added, “Providing false information to shareholders and asking them to support them is a very high risk. It is said that he advised Hanmi Science, “It can be seen as interfering with legitimate shareholder management, operation of the general shareholders’ meeting, and ongoing work.”
Hanmi Science, the holding company of Hanmi Group, is scheduled to hold an extraordinary shareholders’ meeting on the 28th. The agenda includes a change in the articles of incorporation to increase the number of board members from the current 10 to 11, the appointment of two directors, Chairman Shin Dong-guk and Vice Chairman Lim Joo-hyun, and a shareholder-friendly policy of reduced dividends.
On this day, the management of Hanmi Science said, “The amendment to the Articles of Incorporation requested by the three-party alliance requires the approval of more than 2/3 of the number of shares present and 1/3 of the total number of issued shares, so rejection is virtually certain with the current shareholding structure.” He predicted, “It is difficult to predict the outcome of the election of internal directors depending on where the shareholders’ votes are directed, and the case of reduced dividends will be passed easily as long as there are no surprises.”
3-person coalition “The excessive filing of complaints and accusations is the true face of dictatorial management that ignores procedures and regulations”
In relation to this criminal complaint, the three-member coalition of Hanmi Science said in the ‘Three-member coalition statement on the abuse of complaints against Hanmi Science’, “According to the regulations of the board of directors of Hanmi Science, the filing of an important lawsuit must be approved by the board of directors.” “Hanmi Science’s action of filing a criminal complaint against Hanmi Science’s largest shareholder and executive director is of course an important lawsuit, and therefore, it is judged that it must be approved by the board of directors,” he said.
He continued, “It is said that when you see one, you know ten. “It is showing the true face of dictatorial management that ignores procedures and regulations and crosses the line between illegality and illegality based solely on the influence of brothers,” he said. We ask that you please make a judgment at this extraordinary general meeting. “Please join forces for a special resolution,” he appealed.
The heated management dispute between family members also raises suspicions about whether she is the biological mother.
Meanwhile, the late Chairman Lim Seong-gi, who founded Hanmi Pharmaceuticals, is known to have two sons and one daughter with Chairman Song Young-sook. They are the eldest son, Lim Jong-yoon, executive director of Hanmi Science (born in 1972), his daughter, Lim Joo-hyun, vice chairman of Hanmi Pharmaceutical Group (born in 1974), and the second son, Lim Jong-hoon, CEO of Hanmi Science (born in 1977).
However, at Hanmi Pharmaceutical Group, the mother, Chairman Song Young-sook, her daughter, Vice Chairman Lim Ju-hyun, mother and daughter, and the eldest son, executive director Lim Jong-yoon, and the second son, CEO Lim Jong-hoon, are all on the same side over how to pay the inheritance tax exceeding 500 billion won imposed on the family after Chairman Lim’s death. Conflicts have been brewing, and a heated situation has developed where the son accuses his mother.
Because of this, suspicions are rising in the industry that Chairman Song Young-sook may not be the biological mother of brothers Lim Jong-yoon and Jong-hoon. In relation to this, an official from Hanmi Pharmaceutical recently confirmed in a phone call with Health Korea News, “The rumors floating around in the market are nonsense,” and “Chairman Song Young-sook is the biological mother of the two brothers.”
Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited
Source: www.hkn24.com
